Przejdź do treści

Filtry

Dane naukowe

Podręcznik/instrukcje

Aktualności

Chuanxiong-type preparations for acute ischemic stroke

Stroke is a common disorder. It is due either to blockage of an artery in the brain or to bleeding in the brain. Chuanxiong is a Traditional Chinese Medicine. It is widely used in China for the treatment of patients with stroke. Two poor quality trials involving 161 participants were included in this review. The authors did not find any strong evidence about its effects. Well-designed and conducted trials will be needed to provide reliable evidence to show whether this intervention does more good than harm.

Wprowadzenie

Stroke, 88% of which are ischemic, is a common cause of death and disability all over the world. Chuanxiong has been reported to be beneficial in treating stroke. However, the strength of evidence to support its use is unclear.

Cele

To assess the safety and efficacy of chuanxiong for acute ischemic stroke.

Metody wyszukiwania badań

We searched the Cochrane Stroke Group Trials Register (last searched January 2008), the Chinese Stroke Trials Register (last searched December 2007), the trials register of the Cochrane Complementary Medicine Field (last searched December 2007), the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 4, 2007), MEDLINE (1966 to December 2007), EMBASE (1980 to December 2007), CNKI (1979 to December 2007), AMED (1985 to December 2007) and CBM-disc (1979 to December 2007). We also handsearched appropriate journals and relevant conference proceedings and searched ongoing trials and research registers.

Kryteria doboru badań

All randomised controlled trials comparing the clinical outcomes of chuanxiong with placebo or no treatment in patients with acute ischemic stroke (within 14 days of onset).

Zbieranie i analiza danych

Two review authors independently selected trials for inclusion, four review authors interviewed study authors to confirm randomisation, and two review authors assessed trial quality, extracted and analysed data.

Główne wyniki

Two trials involving 161 participants were included. Both trials were of low quality. Neither of the trials reported the mortality rate or dependency of the participants and no reliable evidence is available in this review.

Wnioski autorów

In the two poor quality trials published, there is insufficient evidence to suggest any clinical recommendations. Well-designed and performed high-quality trials are needed.

Cytowanie
Yuan Y, Zeng X, Luo Y, Li Z, Wu T. Chuanxiong-type preparations for acute ischemic stroke. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD005569. DOI: 10.1002/14651858.CD005569.pub2.

Używamy plików cookie

Używamy niezbędnych plików cookie, aby nasza strona mogła działać. Chcielibyśmy również ustawić opcjonalne pliki cookie do analizy, aby pomóc nam udoskonalić tę stronę. Nie będziemy ustawiać opcjonalnych plików cookie, chyba że je włączysz. Użycie tego narzędzia spowoduje ustawienie pliku cookie na Twoim urządzeniu, aby zapamiętać Twoje preferencje. W każdej chwili możesz zmienić swoje preferencje dotyczące plików cookie, klikając na link "Ustawienia plików cookie" znajdujący się w stopce każdej strony.
Bardziej szczegółowe informacje na temat używanych przez nas plików cookie można znaleźć na naszej stronieStrona plików cookies

Zaakceptuj wszystkie
Skonfiguruj